| TAK-441 |
TAK-441 |
1186231-83-3 |
| CH5132799 |
CH5132799 |
1007207-67-1 |
| Pictilisib |
GDC-0941 |
957054-30-7 |
| BKM120 (NVP-BKM120, Buparlisib) |
BKM-120 |
944396-07-0 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| BIBF-1120 |
BIBF-1120 |
928326-83-4 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-26-8 |
| Pracinostat |
(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 |
929016-96-6 |
| N-[2,4-Difluoro-3-[[5-(3-pyridinyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]phenyl]-2-propanesulfonamide |
N-[2,4-二氟-3-[[5-(3-吡啶基)-1H-吡咯并[2,3-B]吡啶-3-基]羰基]苯基]-2-丙磺酰胺 |
918505-61-0 |
| ABT 263 |
ABT 263 |
923564-51-6 |
| ABC294640 |
3-(4-氯苯基)-N-(4-吡啶基甲基)金刚烷-1-甲酰胺 |
915385-81-8 |
| 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 |
905854-02-6 |
| Pevonedistat |
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯 |
905579-51-3 |
| 3-[(3-Methoxybenzoyl)aMino]-4-(4-Methyl-1-piperazinyl)benzoic Acid Methyl Ester |
WDR5 0103 |
890190-22-4 |
| LY2334737 |
2'-脱氧-2',2'-二氟-N-(1-氧代-2-丙基戊基)胞苷 |
892128-60-8 |
| 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide |
维莫德吉 |
879085-55-9 |
| NVP-BGJ398 |
FGFR抑制剂(NVP-BGJ398) |
872511-34-7 |
